Blog

Top Science and Technology Breakthroughs of 2025 The year 2025 is shaping up to be a landmark period for scientific and technological advancements. From artificial intelligence to space exploration, groundbreaking innovations are set to redefine industries and improve lives. In this article, we’ll explore the most exciting breakthroughs expected in 2025, offering a glimpse into […]

Can High HDL Cholesterol Worsen Glaucoma Risk? Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While high intraocular pressure (IOP) is a well-known risk factor, emerging research suggests that cholesterol levels—particularly high-density lipoprotein (HDL) cholesterol—may also play a role. But could high HDL cholesterol actually worsen glaucoma risk? Let’s explore

Preventable Glaucoma Vision Loss Hindered by Treatment Costs Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. Yet, what makes this condition even more tragic is that much of the vision loss it causes is preventable with timely diagnosis and treatment. Unfortunately, the high cost of glaucoma care creates significant barriers

National Reconstruction Fund Invests $27M in Glaucoma Treatment Innovation The National Reconstruction Fund (NRF) has announced a groundbreaking investment of $27 million into cutting-edge glaucoma treatment innovation. This significant funding aims to accelerate research, development, and commercialization of advanced therapies to combat glaucoma—a leading cause of irreversible blindness worldwide. The move underscores the government’s commitment

Understanding Age-Related Glaucoma Progression: Key Insights Glaucoma is a leading cause of irreversible blindness worldwide, particularly affecting older adults. As we age, the risk of developing glaucoma increases, making it crucial to understand how this condition progresses over time. Early detection and proper management can help preserve vision and improve quality of life. In this

Preventable Glaucoma Vision Loss Hindered by Treatment Costs Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. Shockingly, much of the vision loss caused by this condition is preventable—if detected early and treated properly. However, a major barrier stands in the way: the high cost of treatment. Many

HELIOS Trial Insights: Dr. Dilsher S. Dhoot on Diabetic Retinopathy Breakthroughs Diabetic retinopathy (DR) remains one of the most common and devastating complications of diabetes, affecting millions worldwide. The HELIOS trial has emerged as a groundbreaking study, offering new hope for patients battling this vision-threatening condition. In this article, we delve into the key insights